Most injuries heal. That is the part worth saying first, because a page like this attracts people for whom it did not happen, and the base rate matters. In the pooled data on first-time lateral ankle sprains, residual pain fell from 48.6% at three months to 6.7% at twelve. The curve keeps improving for a year.
This article is about the tail of that curve. What is biologically different about the injuries that are still there when everyone else has forgotten theirs?
Normal repair has three phases, and the third one is where things go wrong
Inflammatory, proliferative, remodeling. The first two are robust; they run on autopilot in almost everyone. The third is slow, conditional, and dependent on inputs that are easy to get wrong.
In remodeling, the fast provisional type III collagen laid down in the proliferative phase is progressively replaced by type I, and the new fibers align to the direction of mechanical load. Two inputs govern it: a metabolic budget adequate to synthesize and cross-link the new matrix, and a mechanical signal telling the fibers which way to point. Take away either and the provisional matrix simply stays.
What a stalled repair looks like under the microscope
The tissue that results is not inflamed, which is why the suffix in tendonitis is misleading and why anti-inflammatory strategies aimed at it disappoint. What is found instead is disorganized collagen, increased ground substance, neovascularization — small vessels growing into tissue that should be relatively avascular — and, alongside those vessels, new nerve fibers.
That last detail explains a great deal of clinical confusion. The structure is now innervated in a way it was not before, so it generates pain out of proportion to its mechanical state. A patient describes severe pain; an image shows a tendon that looks tolerable; somebody concludes the problem is exaggerated. The problem is real and it is not primarily a strength problem or an inflammation problem. It is a failed-remodeling problem.
Why it stalls: four inputs, in order of how often they are the culprit
1. The mechanical signal was withdrawn
Remodeling collagen aligns to load. Remove load — through pain avoidance, immobilization, or a rehabilitation program that stopped when walking stopped hurting — and there is nothing telling the fibers where to point. This is the most common reversible cause and the least glamorous.
It is also the one with the best treatment evidence. A 2026 network meta-analysis of exercise interventions for patellar tendinopathy found that no intervention showed clear superiority over heavy slow resistance training, with the authors cautioning that the rankings are exploratory. Read carefully, that is a useful finding rather than a disappointing one: the specific protocol matters less than that progressive load is actually applied.
2. The metabolic budget was not there
Collagen synthesis and cross-linking are expensive and they depend on substrate and on hormonal and inflammatory context. Pooled risk factors for rotator cuff tendinopathy turn out to be metabolic and systemic more than they are mechanical. Insulin resistance, poor sleep, low vitamin D status and continued nicotine exposure are the recurring four, and each has its own article — vitamin D, sleep and nicotine.
3. The problem was never the structure everyone was treating
A repair cannot stall in a tissue that was not injured. Where a diagnosis was assumed from an imaging report rather than established by examination and, where appropriate, by response to a diagnostic block, months of correct treatment can be delivered to the wrong target.
4. There was too much load, applied wrongly
The mirror image of the first cause, and less common. Continued high load on a tissue in the middle of remodeling perpetuates the proliferative state. The distinction between progressive loading and repeated re-injury is a clinical judgment, not a formula.
Where a catalyst fits, and where the evidence says it does not
A stalled repair is the state a biologic is designed for, and it is the state the positive trials recruited. It is also a field where results vary more than they should, and the commonest reason is not the biology. It is that the treatments being compared were never the same treatment, and the patients receiving them were never sorted by whether their terrain could execute the instruction.
Part of the variability is that trials in this field are poorly characterized. A systematic review found that randomized trials of platelet-rich plasma for knee osteoarthritis adhere badly to the MIBO reporting standard, which means pooled analyses are comparing treatments that were never the same treatment. Why the preparation is a clinical decision here is covered in Why PRP Results Vary.
The order that restarts one
Confirm the target. Correct the terrain. Reintroduce progressive load and keep it going past the point where it stops hurting. Then, where a target and a window justify it, deliver a characterized catalyst under imaging guidance. Reversing that order is the commonest way regenerative treatment is wasted.
Frequently Asked Questions
What does it mean when a doctor says my injury has healed but it still hurts?
Usually that the acute injury resolved and the remodeling phase did not complete, leaving disorganized matrix with ingrown vessels and nerve fibers that behaves nothing like the original problem. Why the resulting tissue is not inflamed in the way the word tendonitis implies is covered in Tendon PRP versus intra-articular PRP.
Why did my injection not work?
The commonest reasons are a target that was never confirmed, a preparation nobody characterized, and a biological environment that could not execute the signal — in roughly that order of frequency. Each is worked through in Why PRP Injections Fail.
Does smoking really matter for a tendon injury?
Yes, and nicotine specifically rather than only combustion products, because vasoconstriction and impaired collagen cross-linking act directly on the process being asked to complete. The detail, including what happens with vaping and pouches, is in Nicotine and smoking effects on tendon and bone healing.
Is a stalled injury still treatable years later?
Yes. Every positive trial in this literature recruited people whose problem had already lasted months or years, so a long history is a qualification for assessment rather than a disqualification from it. What changes with time is the realistic target, which is the distinction drawn in Realistic recovery timelines after orthobiologic treatment.
How do you tell a stalled repair from something that was misdiagnosed?
By re-examining the mechanism rather than rereading the report, because a repair that never started on the right structure is a different problem from one that started and stopped. The reasoning is the same one applied in Your Scan Came Back Clean and You Are Still in Pain.
Find out what your recovery is actually limited by
Regen.MD begins with a physician-led Clinical Evaluation — a review of your history, your imaging and your metabolic data, and a written terrain roadmap before any procedure is discussed. Evaluation is contingent upon review of your data.
Questions? Call (314) 295-3000 or text (314) 886-5902.
Sources
- Liu Y, Li C, Yang F. Comparative effectiveness of exercise interventions for patellar tendinopathy: a systematic review and network meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil, 2026. PubMed 42192475 doi:10.1186/s13102-026-01743-4
- Leong HT, Fu SC, He X, et al. Risk factors for rotator cuff tendinopathy: a systematic review and meta-analysis. J Rehabil Med, 2019. PubMed 31489438 doi:10.2340/16501977-2598
- D'Souza RS, Her YF, Hussain N, et al. Evidence-based clinical practice guidelines on regenerative medicine treatment for chronic pain: a consensus report from a multispecialty working group. J Pain Res, 2024. PubMed 39282657 doi:10.2147/JPR.S480559
- Manchikanti L, Navani R, Navani A, et al. Comprehensive evidence-based guidelines for regenerative therapies in the management of chronic low back pain: 2025 update from the American Society of Interventional Pain Physicians (ASIPP). Pain Physician, 2025. PubMed 41481869
- Stone AV, Abed V, Owens M, et al. Randomized controlled trials on platelet-rich plasma for knee osteoarthritis poorly adhere to the Minimum Information for Studies Evaluating Biologics in Orthopaedics (MIBO) guidelines: a systematic review. Am J Sports Med, 2024. PubMed 38282598 doi:10.1177/03635465231185289
- Michels F, Wastyn H, Pottel H, Stockmans F. The presence of persistent symptoms 12 months following a first lateral ankle sprain: a systematic review and meta-analysis. Foot Ankle Surg, 2022. PubMed 34961654 doi:10.1016/j.fas.2021.12.002
- Bensa A, Sangiorgio A, Deabate L, et al. PRP injections for the treatment of knee osteoarthritis: the improvement is clinically significant and influenced by platelet concentration — a meta-analysis of randomized controlled trials. Am J Sports Med, 2025. PubMed 39751394 doi:10.1177/03635465241246524